Anthrax
📧 Sign up to get email alerts when something new happens for Anthrax.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Anthrax AV7909 Boost Evaluation Study [Phase 2]
This ClinicalTrials.gov entry reports a Phase 2 study evaluating the Anthrax vaccine AV7909 booster, and it is currently active but not recr…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Anthrax AV7909 Liquid vs Lyophilized [Phase 1]
Phase 1 trial comparing liquid versus lyophilized AV7909 anthrax vaccine formulations completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change [Phase 4]
Phase 4 trial evaluating dose reduction and route changes for an anthrax vaccine in healthy participants; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-07-14Clinical Trial Update: An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis [Phase 4]
Open-label Phase 4 study evaluating Anthim (obiltoxaximab) in individuals exposed to Bacillus anthracis (anthrax).
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 [Phase 2]
Phase 2 trial evaluating dose-response, efficacy (immunogenicity) and safety of GC1109 for anthrax has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: VELOCITY: An Anthrax Vaccine Clinical Study [Phase 3]
Phase 3 clinical trial update for an anthrax vaccine (VELOCITY) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study [Phase 2]
Phase 2 trial evaluating an anthrax vaccine (BioThrax) in combination with antibiotics has completed, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: BARDA Securing Anthrax Immunity For the Elderly [Phase 2]
Phase 2 trial update on BARDA-supported anthrax immunity in the elderly has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-13Clinical Trial Update: Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV) [Phase 1, Phase 2]
Phase 1/2 safety and pharmacokinetics study of Anthrax Immune Globulin Intravenous (AIGIV) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed [Phase 4]
Phase 4 clinical trial assessing the effect of raxibacumab on the immunogenicity of Anthrax Vaccine Adsorbed has been completed with results…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers [Phase 1]
Phase 1, single-dose, weight-based dose-escalation intravenous study of ETI-204 in healthy adult volunteers has completed; the trial evaluat…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects [Phase 1]
This Phase 1 trial of anthrax vaccines Px563L and RPA563 in healthy adults has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Anthrax Vaccine Clinical Trials [Phase 1]
Phase 1 clinical trials of an anthrax vaccine sponsored by NICHD have been completed, reporting early safety and immunogenicity data.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine [Phase 1]
Phase 1 clinical trial of PA83-FhCMB plant-derived recombinant protective antigen (rPA) anthrax vaccine completed; the sponsor reports the s…
-
CLINICAL_TRIALS trial_result · 2015-02-24Clinical Trial Update: A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels [Phase 2]
Phase 2 safety and immunogenicity study of an anthrax vaccine using three schedules and two dose levels has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Ciprofloxacin BioThrax Co-Administration Study [Phase 2]
A Phase 2 study evaluating the co-administration of ciprofloxacin with BioThrax (anthrax vaccine adsorbed) in anthrax conditions; results we…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults [Phase 1]
Phase 1 study assessing safety, tolerability, and immunogenicity of AV7909 anthrax vaccine in healthy adults completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule [Phase 4]
A Phase 4 study evaluating the immunogenicity and safety of a dose-sparing schedule for BioThrax (anthrax vaccine adsorbed) completed with r…
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects [Phase 1]
This Phase 1 dose-escalation study of Valortim (MDX-1303) administered intravenously in healthy subjects has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults [Phase 3]
Phase 3 trial update on a three-dose BioThrax regimen for post-exposure prophylaxis in healthy adults, focusing on immunogenicity and safety…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Efficacy and Safety of Anthrax Vaccine, GC1109 [Phase 1]
This update reports the completion of a Phase 1 clinical trial evaluating the safety and potential efficacy of the GC1109 Anthrax Vaccine co…
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults [Phase 1]
A Phase 1 study evaluated a new intramuscular anthrax vaccine in healthy adults and has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Anthrax-rPA: Safety, Tolerability, Immunogenicity [Phase 1]
Phase 1 trial of Anthrax-rPA evaluated safety, tolerability, and immunogenicity and has completed, reporting early safety and immune respons…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: UMD rPA Regimen Trial in Adults [Phase 2]
A Phase 2 trial evaluating the UMD rPA regimen in adults with anthrax has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-08-10Clinical Trial Update: Ph1 Study of Valortim and Doxycycline in Humans [Phase 1]
A Phase 1 study evaluating Valortim in combination with doxycycline for anthrax was terminated. The trial status was TERMINATED.